Arch Biopartners Inc (ACHFF)
1.29
-0.01
(-0.77%)
USD |
OTCM |
May 03, 16:00
Arch Biopartners PS Ratio
PS Ratio Chart
Historical PS Ratio Data
| Date | Value |
|---|---|
| March 30, 2015 | 178.47 |
| March 27, 2015 | 178.47 |
| March 26, 2015 | 178.47 |
| March 25, 2015 | 178.47 |
| March 24, 2015 | 178.47 |
| March 23, 2015 | 178.47 |
| March 20, 2015 | 178.47 |
| March 19, 2015 | 178.47 |
| Date | Value |
|---|---|
| March 18, 2015 | 178.47 |
| March 17, 2015 | 178.47 |
| March 16, 2015 | 178.47 |
| March 13, 2015 | 178.47 |
| March 12, 2015 | 178.47 |
| March 11, 2015 | 178.47 |
| December 31, 2014 | 187.37 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PS Ratio Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 4.155 |
| Edesa Biotech Inc | 42.22 |
| Lexaria Bioscience Corp | 69.67 |
| Xenon Pharmaceuticals Inc | 222.18 |
PS Ratio Related Metrics
| PEG Ratio | -0.2087 |
| Price | 1.29 |
| Earnings Yield | -1.77% |
| Market Cap | 80.95M |
| PEGY Ratio | -0.2087 |